These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7706285)

  • 1. Cellular proliferation and activation of NF kappa B are induced by autocrine production of tumor necrosis factor alpha in the human T lymphoma line HuT 78.
    O'Connell MA; Cleere R; Long A; O'Neill LA; Kelleher D
    J Biol Chem; 1995 Mar; 270(13):7399-404. PubMed ID: 7706285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the interleukin-10 gene in the human T lymphoma line HuT 78: identification and characterization of NF-kappa B binding sites in the regulatory region of the interleukin-10 gene.
    Mori N; Prager D
    Eur J Haematol; 1997 Sep; 59(3):162-70. PubMed ID: 9310124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constitutive activation of NF-kappaB causes resistance to apoptosis in human cutaneous T cell lymphoma HuT-78 cells. Autocrine role of tumor necrosis factor and reactive oxygen intermediates.
    Giri DK; Aggarwal BB
    J Biol Chem; 1998 May; 273(22):14008-14. PubMed ID: 9593751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NF-kappa B activation by tumor necrosis factor alpha in the Jurkat T cell line is independent of protein kinase A, protein kinase C, and Ca(2+)-regulated kinases.
    Feuillard J; Gouy H; Bismuth G; Lee LM; Debré P; Körner M
    Cytokine; 1991 May; 3(3):257-65. PubMed ID: 1653056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies into the effect of the tyrosine kinase inhibitor herbimycin A on NF-kappa B activation in T lymphocytes. Evidence for covalent modification of the p50 subunit.
    Mahon TM; O'Neill LA
    J Biol Chem; 1995 Dec; 270(48):28557-64. PubMed ID: 7499370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autocrine regulation of the transcription factor NF kappa B by TNF alpha in the human T cell lymphoma line Hut 78.
    Cleere R; Long A; Kelleher D; O'Neill LA
    Biochem Soc Trans; 1995 Feb; 23(1):113S. PubMed ID: 7758674
    [No Abstract]   [Full Text] [Related]  

  • 7. Activation of nuclear factor kappa B in human neuroblastoma cell lines.
    Körner M; Tarantino N; Pleskoff O; Lee LM; Debré P
    J Neurochem; 1994 May; 62(5):1716-26. PubMed ID: 8158122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin 1 induces HIV-1 expression in chronically infected U1 cells: blockade by interleukin 1 receptor antagonist and tumor necrosis factor binding protein type 1.
    Granowitz EV; Saget BM; Wang MZ; Dinarello CA; Skolnik PR
    Mol Med; 1995 Sep; 1(6):667-77. PubMed ID: 8529133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein kinases negatively affect nuclear factor-kappa B activation by tumor necrosis factor-alpha at two different stages in promyelocytic HL60 cells.
    Hohmann HP; Remy R; Aigner L; Brockhaus M; van Loon AP
    J Biol Chem; 1992 Jan; 267(3):2065-72. PubMed ID: 1730737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor-alpha, interleukin 1, and phorbol myristate acetate are independent activators of NF-kappa B which differentially activate T cells.
    Krasnow SW; Zhang LQ; Leung KY; Osborn L; Kunkel S; Nabel GJ
    Cytokine; 1991 Sep; 3(5):372-9. PubMed ID: 1751774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinase C-independent activation of nuclear factor kappa B by tumor necrosis factor.
    Meichle A; Schütze S; Hensel G; Brunsing D; Krönke M
    J Biol Chem; 1990 May; 265(14):8339-43. PubMed ID: 2186042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of p38 mitogen-activated protein kinase is required for tumor necrosis factor-alpha -supported proliferation of leukemia and lymphoma cell lines.
    Liu RY; Fan C; Liu G; Olashaw NE; Zuckerman KS
    J Biol Chem; 2000 Jul; 275(28):21086-93. PubMed ID: 10783388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The binding of immobilized IgG2a to Fc gamma 2a receptor activates NF-kappa B via reactive oxygen intermediates and tumor necrosis factor-alpha 1.
    Muroi M; Muroi Y; Suzuki T
    J Biol Chem; 1994 Dec; 269(48):30561-8. PubMed ID: 7982975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble tumor necrosis factor receptors inhibit phorbol myristate acetate and cytokine-induced HIV-1 expression chronically infected U1 cells.
    Granowitz EV; Saget BM; Angel JB; Wang MZ; Wang A; Dinarello CA; Skolnik PR
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Apr; 11(5):430-7. PubMed ID: 8605587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of NF-kappa B activation in human T-cell lines by anetholdithiolthione.
    Sen CK; Traber KE; Packer L
    Biochem Biophys Res Commun; 1996 Jan; 218(1):148-53. PubMed ID: 8573121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein-tyrosine phosphatase inhibitors block tumor necrosis factor-dependent activation of the nuclear transcription factor NF-kappa B.
    Singh S; Aggarwal BB
    J Biol Chem; 1995 May; 270(18):10631-9. PubMed ID: 7738000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of interleukin-2 receptor alpha chain expression and nuclear factor.kappa B activation by protein kinase C in T lymphocytes. Autocrine role of tumor necrosis factor alpha.
    Pimentel-Muiños FX; Mazana J; Fresno M
    J Biol Chem; 1994 Sep; 269(39):24424-9. PubMed ID: 7929104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ET-18-OCH3 inhibits nuclear factor-kappa B activation by 12-O-tetradecanoylphorbol-13-acetate but not by tumor necrosis factor-alpha or interleukin 1 alpha.
    Daniel LW; Civoli F; Rogers MA; Smitherman PK; Raju PA; Roederer M
    Cancer Res; 1995 Nov; 55(21):4844-9. PubMed ID: 7585518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquisition of cellular resistance to 9-nitro-camptothecin correlates with suppression of transcription factor NF-kappa B activation and potentiation of cytotoxicity by tumor necrosis factor in human histiocytic lymphoma U-937 cells.
    Singh S; Raju U; Mendoza J; Pantazis P; Aggarwal BB
    Anticancer Drugs; 1998 Sep; 9(8):703-14. PubMed ID: 9823429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A sustained reduction in IkappaB-beta may contribute to persistent NF-kappaB activation in human endothelial cells.
    Johnson DR; Douglas I; Jahnke A; Ghosh S; Pober JS
    J Biol Chem; 1996 Jul; 271(27):16317-22. PubMed ID: 8663191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.